R
Ridgerunner
Guest
Some the U.S. could have done. Some it could not have done.Clearly, South Korea did it right and the US did it wrong. South Korea has a few hundred dead from COVID and the US has over 100,000. So, the US should have done what South Korea did.
So Ko started preparing for a pandemic of this sort in 2015 because of the MERS infections, and had a test methodology before Covid’s first infection there. The U.S. could have done that, but did not in a credible way.
So Ko started widespread testing in January. CDC did not allow it until early March and funneled all testing through itself according to a longstanding protocol. That did not have to happen.
So Ko did widespread and intensive source tracing even including publication of identities and places where they had been. That couldn’t happen in the U.S. in quite the same way because of HIPAA and because CDC didn’t release test results in an openly identifiable way.
It also appears So Ko has been more eclectic in its methods of treatment and seems faster than FDA in getting meds, including preventive meds, on line. It would seem the U.S. could do better in regard to both things.